Marshall Wace LLP boosted its position in TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 21.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 67,855 shares of the company's stock after buying an additional 11,962 shares during the period. Marshall Wace LLP owned approximately 0.45% of TruBridge worth $1,338,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Federated Hermes Inc. lifted its holdings in TruBridge by 3.1% in the fourth quarter. Federated Hermes Inc. now owns 468,758 shares of the company's stock valued at $9,244,000 after buying an additional 14,120 shares during the period. Truffle Hound Capital LLC bought a new position in shares of TruBridge during the 4th quarter worth about $5,916,000. Geode Capital Management LLC bought a new stake in TruBridge in the 3rd quarter valued at about $1,747,000. JPMorgan Chase & Co. increased its position in TruBridge by 73.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 112,240 shares of the company's stock valued at $1,342,000 after buying an additional 47,507 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in TruBridge by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 73,879 shares of the company's stock worth $1,457,000 after buying an additional 716 shares during the period. Institutional investors and hedge funds own 88.64% of the company's stock.
TruBridge Stock Up 0.4 %
Shares of NASDAQ:TBRG opened at $25.44 on Tuesday. The stock has a market cap of $380.30 million, a price-to-earnings ratio of -6.22, a PEG ratio of 5.38 and a beta of 0.64. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00. TruBridge, Inc. has a 12-month low of $7.75 and a 12-month high of $32.00. The business's 50 day moving average is $26.91 and its 200 day moving average is $21.81.
Insider Activity at TruBridge
In other TruBridge news, major shareholder Pinetree Capital Ltd. acquired 6,795 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were acquired at an average price of $28.16 per share, with a total value of $191,347.20. Following the completion of the transaction, the insider now owns 729,176 shares in the company, valued at approximately $20,533,596.16. This trade represents a 0.94 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Christopher L. Fowler sold 5,100 shares of the business's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $27.02, for a total value of $137,802.00. Following the completion of the transaction, the chief executive officer now directly owns 142,939 shares in the company, valued at approximately $3,862,211.78. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have purchased a total of 116,728 shares of company stock valued at $3,239,879 over the last 90 days. Insiders own 10.70% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on TBRG shares. Stephens reissued an "equal weight" rating and issued a $28.00 price objective on shares of TruBridge in a research note on Thursday, April 10th. Cantor Fitzgerald raised their price objective on TruBridge from $20.00 to $29.00 and gave the company an "overweight" rating in a research note on Tuesday, March 11th.
Get Our Latest Stock Analysis on TBRG
About TruBridge
(
Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
See Also
Want to see what other hedge funds are holding TBRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TruBridge, Inc. (NASDAQ:TBRG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
